By David Voreacos April 29 (Bloomberg) — Two units of Johnson & Johnson will pay more than $81 million to resolve criminal and civil claims
“At the heart of many of the issues the American people count on their leaders to address are simple, shared principles: justice and fairness. These
For $520 Million, AstraZeneca Will Settle Case Over Marketing of a Drug By DUFF WILSON AstraZeneca has completed a deal to pay $520 million to
African-American farmers hoping for government settlement money in a racial bias case met with lawmakers Wednesday and called on Congress to come up with a
By MATTHEW PERRONE (AP) – 18 hours ago WASHINGTON — Federal regulators say the drugmaker Pfizer has failed to correct problems with its testing procedures
By Elaine Meyer Law360, New York (April 20, 2010) — Harrah’s Entertainment Inc. is facing a proposed collective and class action that accuses the company
WASHINGTON, April 16 (Reuters) – GlaxoSmithKline Plc , Novartis AG and Astellas Pharma Inc <4503.T> used misleading promotions for cancer, pain and bladder drugs, U.S.
April 9 (Bloomberg) — Amylin Pharmaceuticals Inc. and Eli Lilly & Co.’s long-acting Byetta may be tied to increased cancer risk, a top U.S. regulator